Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AstraZeneca PLC (NYSE:AZN)

30.03
Delayed Data
As of Feb 05
 -0.44 / -1.44%
Today’s Change
29.50
Today|||52-Week Range
36.69
-11.55%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues6.4B5.7B6.2B5.9B
 
 
 
 
 
Cost of Goods Sold582.1M353.0M287.2M444.9M
 
 
 
 
 
Depreciation And Amortization972.8M794.8M701.8M568.3M
 
 
 
 
 
 
Operating ExpensesGross Income4.8B4.5B5.2B4.9B
 
 
 
 
 
General Expenses5.0B3.8B4.3B4.0B
 
 
 
 
 
Other Operating Expenses0.0058.0M60.8M55.7M
 
 
 
 
Research And Development1.2B1.2B1.4B1.4B
 
 
 
 
 
Total Operating Expenses6.5B5.0B5.3B5.0B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-159.1M661.9M879.3M870.8M
 
 
 
 
 
Extraordinary Charge-372.5M-199.4M-230.4M-213.0M
 
 
 
 
 
Interest Expense On Debt247.7M244.4M270.5M244.8M
 
 
 
 
 
Equity In Earnings-3.8M-4.7M-2.0M-2.0M
 
 
 
 
 
Other Expenses230.6M421.3M268.6M515.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-548.8M639.4M646.9M928.6M
 
 
 
 
 
Income Taxes-246.8M-118.0M-37.2M-160.2M
 
 
 
 
 
Minority Interest0.00-1.9M-980.2K--
 
 
 
Net Income-305.8M514.9M683.2M766.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.5B2.5B2.5B2.5B
 
 
 
 
 
Shares To Calculate EPS Diluted2.6B2.5B2.5B2.5B
 
 
 
 
 
 
Earnings Per ShareEPS-$0.12$0.21$0.27$0.30
 
 
 
 
 
EPS Diluted-$0.12$0.20$0.27$0.30